tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AU:CHM Stock Latest News

Chimeric Therapeutics Announces Change in Substantial Shareholding
Company AnnouncementsChimeric Therapeutics Announces Change in Substantial Shareholding
4d ago
CHM
Chimeric Therapeutics Director Increases Stake Through Entitlement Offer
PremiumCompany Announcements
Chimeric Therapeutics Director Increases Stake Through Entitlement Offer
4d ago
CHM
Chimeric Therapeutics Director Increases Stake Through Entitlement Offer
PremiumCompany Announcements
Chimeric Therapeutics Director Increases Stake Through Entitlement Offer
4d ago
CHM
Chimeric Therapeutics Issues New Securities to Bolster R&D
PremiumCompany Announcements
Chimeric Therapeutics Issues New Securities to Bolster R&D
5d ago
CHM
Chimeric Therapeutics Expands CHM CDH17 Clinical Trial to Emory Winship Cancer Institute
PremiumCompany Announcements
Chimeric Therapeutics Expands CHM CDH17 Clinical Trial to Emory Winship Cancer Institute
11d ago
CHM
Chimeric Therapeutics Completes $1 Million Entitlement Offer to Advance Cancer Therapies
PremiumCompany AnnouncementsChimeric Therapeutics Completes $1 Million Entitlement Offer to Advance Cancer Therapies
11d ago
CHM
Chimeric Therapeutics Advances CAR-T Trials with New Collaborations and Funding
Premium
Company Announcements
Chimeric Therapeutics Advances CAR-T Trials with New Collaborations and Funding
12d ago
CHM
Chimeric Therapeutics Lists Options on ASX to Boost Market Engagement
Premium
Company Announcements
Chimeric Therapeutics Lists Options on ASX to Boost Market Engagement
1M ago
CHM
Chimeric Therapeutics Extends Entitlement Offer Deadline
PremiumCompany Announcements
Chimeric Therapeutics Extends Entitlement Offer Deadline
1M ago
CHM
Chimeric Therapeutics Announces Shareholder Structure Analysis
PremiumCompany Announcements
Chimeric Therapeutics Announces Shareholder Structure Analysis
1M ago
CHM
Chimeric Therapeutics Announces New ASX Quotation for Options
PremiumCompany Announcements
Chimeric Therapeutics Announces New ASX Quotation for Options
1M ago
CHM
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer
PremiumCompany Announcements
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer
1M ago
CHM
Chimeric Therapeutics Announces Proposed Issue of 25 Million Securities
PremiumCompany AnnouncementsChimeric Therapeutics Announces Proposed Issue of 25 Million Securities
2M ago
CHM
Chimeric Therapeutics Updates Proposed Securities Issue
Premium
Company Announcements
Chimeric Therapeutics Updates Proposed Securities Issue
2M ago
CHM
Chimeric Therapeutics Announces $3.2 Million Entitlement Offer
Premium
Company Announcements
Chimeric Therapeutics Announces $3.2 Million Entitlement Offer
2M ago
CHM
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer to Advance Cancer Trials
PremiumCompany Announcements
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer to Advance Cancer Trials
2M ago
CHM
Chimeric Therapeutics Expands Capital with New Share Issuance
PremiumCompany Announcements
Chimeric Therapeutics Expands Capital with New Share Issuance
2M ago
CHM
Chimeric Therapeutics to Present at NWR Virtual Healthcare Conference
PremiumCompany Announcements
Chimeric Therapeutics to Present at NWR Virtual Healthcare Conference
2M ago
CHM
Chimeric Therapeutics Resumes Trading with New Entitlement Offer
PremiumCompany Announcements
Chimeric Therapeutics Resumes Trading with New Entitlement Offer
2M ago
CHM
Chimeric Therapeutics Announces Proposed Securities Issue to Bolster R&D
PremiumCompany AnnouncementsChimeric Therapeutics Announces Proposed Securities Issue to Bolster R&D
2M ago
CHM
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer to Advance Clinical Trials
Premium
Company Announcements
Chimeric Therapeutics Launches $3.2 Million Entitlement Offer to Advance Clinical Trials
2M ago
CHM
Chimeric Therapeutics Suspends Trading for Capital Raising Announcement
Premium
Company Announcements
Chimeric Therapeutics Suspends Trading for Capital Raising Announcement
2M ago
CHM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >